Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center

David W Baker, Tiffany Brown, David R Buchanan, Jordan Weil, Kenzie A Cameron, Lauren Ranalli, M Rosario Ferreira, Quinn Stephens, Kate Balsley, Shira N Goldman, Michael S Wolf, David W Baker, Tiffany Brown, David R Buchanan, Jordan Weil, Kenzie A Cameron, Lauren Ranalli, M Rosario Ferreira, Quinn Stephens, Kate Balsley, Shira N Goldman, Michael S Wolf

Abstract

Background: Colorectal cancer (CRC) is common and leads to significant morbidity and mortality. Although screening with fecal occult blood testing (FOBT) or endoscopy has been shown to decrease CRC mortality, screening rates remain suboptimal. Screening rates are particularly low for people with low incomes and members of underrepresented minority groups. FOBT should be done annually to detect CRC early and to reduce CRC mortality, but this often does not occur. This paper describes the design of a multifaceted intervention to increase long-term adherence to FOBT among poor, predominantly Latino patients, and the design of a randomized controlled trial (RCT) to test the efficacy of this intervention compared to usual care.

Methods: In this RCT, patients who are due for repeat FOBT are identified in the electronic health record (EHR) and randomized to receive either usual care or a multifaceted intervention. The usual care group includes multiple point-of-care interventions (e.g., standing orders, EHR reminders), performance measurement, and financial incentives to improve CRC screening rates. The intervention augments usual care through mailed CRC screening test kits, low literacy patient education materials, automated phone and text message reminders, in-person follow up calls from a CRC Screening Coordinator, and communication of results to patients along with a reminder card highlighting when the patient is next due for screening. The primary outcome is completion of FOBT within 6 months of becoming due.

Discussion: The main goal of the study is to determine the comparative effectiveness of the intervention compared to usual care. Additionally, we want to assess whether or not it is possible to achieve high rates of adherence to CRC screening with annual FOBT, which is necessary for reducing CRC mortality. The intervention relies on technology that is increasingly widespread and declining in cost, including EHR systems, automated phone and text messaging, and FOBTs for CRC screening. We took this approach to ensure generalizability and allow us to rapidly disseminate the intervention through networks of community health centers (CHCs) if the RCT shows the intervention to be superior to usual care.

Trial registration: ClinicalTrials.gov NCT01453894.

References

    1. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–658. doi: 10.7326/0003-4819-149-9-200811040-00245.
    1. Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians’ colorectal cancer screening recommendations and practices. Prev Med. 2003;36(3):352–362. doi: 10.1016/S0091-7435(02)00066-X.
    1. Centers for Disease Control and Prevention (CDC) Use of colorectal cancer tests–United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57(10):253–258.
    1. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12):1028–1035. doi: 10.1111/j.1525-1497.2003.20807.x.
    1. Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–676. doi: 10.7326/0003-4819-152-10-201005180-00239.
    1. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389–394. doi: 10.1158/1055-9965.EPI-05-0678.
    1. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167(3):258–264. doi: 10.1001/archinte.167.3.258.
    1. Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR. Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis. 2006;3(2):A50.
    1. Jerant AF, Arellanes RE, Franks P. Factors associated with Hispanic/non-Hispanic white colorectal cancer screening disparities. J Gen Intern Med. 2008;23(8):1241–1245. doi: 10.1007/s11606-008-0666-1.
    1. Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006;60(3):202–207. doi: 10.1136/jech.2005.041020.
    1. Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM. Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med. 2010;8(5):397–401. doi: 10.1370/afm.1133.
    1. Gellad ZF, Stechuchak KM, Fisher DA, Olsen MK, McDuffie JR, Ostbye T, Yancy WS Jr. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011;106(6):1125–1134. doi: 10.1038/ajg.2011.11.
    1. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):96–104. doi: 10.7326/0003-4819-137-2-200207160-00007.
    1. Cameron KA, Persell SD, Brown T, Thompson J, Baker DW. Patient outreach to promote colorectal cancer screening among patients with an expired order for colonoscopy: a randomized controlled trial. Arch Intern Med. 2011;171(7):642–646. doi: 10.1001/archinternmed.2010.468.
    1. The Preferred Screening Method For Patients. [ ]
    1. Lohsiriwat V, Thavichaigarn P, Awapittaya B. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. J Med Assoc Thai. 2007;90(11):2291–2295.
    1. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20(3):278–282. doi: 10.1111/j.1525-1497.2005.40023.x.
    1. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90. doi: 10.1053/j.gastro.2008.03.040.
    1. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62–68. doi: 10.1136/gut.2009.177089.
    1. Hassan C, Giorgi Rossi P, Camilloni L, Rex DK, Jimenez-Cendales B, Ferroni E, Borgia P, Zullo A, Guasticchi G, Group H. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther. 2012;36(10):929–940. doi: 10.1111/apt.12071.
    1. Persell SD, Kho AN, Thompson JA, Baker DW. Improving hypertension quality measurement using electronic health records. Med Care. 2009;47(4):388–394. doi: 10.1097/MLR.0b013e31818b070c.
    1. Cialdini RB. Influence: Science and practice, vol. 4. Allyn and Bacon: Boston, MA; 2001.
    1. Festinger L. A Theory of Cognitive Dissonance. Stanford, California: Stanford University Press; 1957.
    1. Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999;91(19):1641–1646. doi: 10.1093/jnci/91.19.1641.
    1. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1232–1235. doi: 10.1158/1055-9965.EPI-05-0916.
    1. Rao SK, Schilling TF, Sequist TD. Challenges in the management of positive fecal occult blood tests. J Gen Intern Med. 2009;24(3):356–360. doi: 10.1007/s11606-008-0893-5.
    1. Levin B, Hess K, Johnson C. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests. Arch Intern Med. 1997;157(9):970–976. doi: 10.1001/archinte.1997.00440300064005.
    1. Miglioretti DL, Rutter CM, Bradford SC, Zauber AG, Kessler LG, Feuer EJ, Grossman DC. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care. 2008;46(9 Suppl 1):S91–S96.
    1. Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum. 2006;49(7):1002–1010. doi: 10.1007/s10350-006-0533-2.
    1. Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol. 2003;98(9):2078–2081. doi: 10.1111/j.1572-0241.2003.07575.x.
    1. Shields HM, Weiner MS, Henry DR, Lloyd JA, Ransil BJ, Lamphier DA, Gallagher DW, Antonioli DA, Rosner BA. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am J Gastroenterol. 2001;96(1):196–203. doi: 10.1111/j.1572-0241.2001.03475.x.
    1. Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med. 2003;18(5):357–363. doi: 10.1046/j.1525-1497.2003.20525.x.
    1. Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European panel of appropriateness of gastrointestinal endoscopy European multicenter study. Gastrointest Endosc. 2005;61(3):378–384. doi: 10.1016/S0016-5107(04)02776-2.
    1. Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc. 2003;58(1):76–79. doi: 10.1067/mge.2003.294.
    1. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Screening for colorectal neoplasia: physicians’ adherence to complete diagnostic evaluation. Am J Public Health. 1993;83(11):1620–1622. doi: 10.2105/AJPH.83.11.1620.
    1. Myers RE, Turner B, Weinberg D, Hyslop T, Hauck WW, Brigham T, Rothermel T, Grana J, Schlackman N. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med. 2004;38(4):375–381. doi: 10.1016/j.ypmed.2003.11.010.
    1. Garman KS, Jeffreys A, Coffman C, Fisher DA. Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci. 2006;332(4):159–163. doi: 10.1097/00000441-200610000-00001.
    1. Ko CW, Dominitz JA, Nguyen TD. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med. 2003;115(2):111–114. doi: 10.1016/S0002-9343(03)00294-8.
    1. Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, Schneider JL, Lafata JE, Myers RE, Kositch M. Automated telephone calls improved completion of fecal occult blood testing. Med Care. 2010;48(7):604–610. doi: 10.1097/MLR.0b013e3181dbdce7.
    1. Maule WF. Screening for colorectal cancer by nurse endoscopists. N Engl J Med. 1994;330(3):183–187. doi: 10.1056/NEJM199401203300307.
    1. Wallace MB, Kemp JA, Meyer F, Horton K, Reffel A, Christiansen CL, Farraye FA. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Am J Med. 1999;107(3):214–218. doi: 10.1016/S0002-9343(99)00225-9.
    1. Schoenfeld PS, Cash B, Kita J, Piorkowski M, Cruess D, Ransohoff D. Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses. Gastrointest Endosc. 1999;49(2):158–162. doi: 10.1016/S0016-5107(99)70480-3.
    1. Sansbury LB, Klabunde CN, Mysliwiec P, Brown ML. Physicians’ use of nonphysician healthcare providers for colorectal cancer screening. Am J Prev Med. 2003;25(3):179–186. doi: 10.1016/S0749-3797(03)00203-4.
    1. Makoul G, Cameron KA, Baker DW, Francis L, Scholtens D, Wolf MS. A multimedia patient education program on colorectal cancer screening increases knowledge and willingness to consider screening among Hispanic/Latino patients. Patient Educ Couns. 2009;76(2):220–226. doi: 10.1016/j.pec.2009.01.006.
    1. Cameron KA, Francis L, Wolf MS, Baker DW, Makoul G. Investigating Hispanic/Latino perceptions about colorectal cancer screening: a community-based approach to effective message design. Patient Educ Couns. 2007;68(2):145–152. doi: 10.1016/j.pec.2007.04.004.
    1. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46(9 Suppl 1):S10–S16.
    1. Palmer RC, Midgette LA, Mullan ID. Colorectal cancer screening preferences among African Americans: which screening test is preferred? J Cancer Educ. 2010;25(4):577–581. doi: 10.1007/s13187-010-0081-2.
    1. Shokar NK, Vernon SW, Weller SC. Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Fam Med. 2005;37(5):341–347.
    1. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23(2):169–174. doi: 10.1007/s11606-007-0480-1.
    1. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96(5):809–811. doi: 10.2105/AJPH.2004.049684.
    1. Chen LA, Santos S, Jandorf L, Christie J, Castillo A, Winkel G, Itzkowitz S. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol. 2008;6(4):443–450. doi: 10.1016/j.cgh.2007.12.009.
    1. Hawley ST, McQueen A, Bartholomew LK, Greisinger AJ, Coan SP, Myers R, Vernon SW. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer. 2012;118(10):2726–2734. doi: 10.1002/cncr.26551.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する